Ibidi , µ-Slide VI 0.4 µ-Pattern RGD, sqr20, pit110, hex Trial Pack: #1.5 polymer coverslip, micropatterned surface with RGD motif, 20 μm squares, 110 μm pitch, hexagonal layout, surface passivation with Bioinert, sterilized, individually packed, 83601-S
The Ibidi µ-Slide VI 0.4 µ-Pattern RGD, sqr20, pit110, hex Trial Pack is a specialized product designed to provide a micropatterned surface with RGD motif. It features a 20 μm square pattern with a 110 μm pitch, arranged in a hexagonal layout. The surface is passivated with Bioinert and is sterilized and individually packed for convenience.
- Benefits/Advantages:
- Precise Micropattern: The product offers a highly precise and consistent micropattern with a well-defined RGD motif, allowing for controlled cell adhesion experiments and studies.
- Versatile Layout: With its hexagonal layout, the trial pack offers a versatile arrangement of micropatterns, suitable for various applications and experiments.
- Surface Passivation: The surface passivation with Bioinert ensures minimal non-specific interactions, providing a clean and controlled environment for cell culture and analysis.
- Sterilized and Individually Packed: Each trial pack is sterilized and individually packed, ensuring product integrity and ease of use.
Product Details
Model | |
---|---|
Product Type | Consumables |
Part Number | 83601-S |
Brand | ibidi GmbH |
Gross Dimensions (WxDxH cm) | |
Net Dimensions (WxDxH cm) | |
Gross Weight (kg) | |
Net Weight (kg) |
ibidi GmbH
ibidi is a leading global supplier for functional cell-based assays and advanced products for cellular microscopy. A shared passion among the team for innovation, quality, service and a strong relationship to the customers, are the keys to ibidi's excellence and success.
ibidi is committed to supplying the highest quality products and service at a good value. Its innovative research tools enabling scientists to achieve outstanding success and breakthroughs in life sciences, pharma, biotechnology, and medical diagnostics. ibidi’s goal is to provide scientists with standardized workflows that result in reproducible and truly objective scientific data, which can also be translated into therapies.